Home › NCT06934564
De-Implementation of Low-value Testing in Patients Undergoing Low-Risk Surgery
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Site Inclusion Criteria: * Over 30% of testing rates on at least one of the three index procedures (breast lumpectomy, laparoscopic cholecystectomy, and inguinal hernia repair) Exclusion Criteria: * none Surgical participants must be over 18 years old.
About the study
This trial aims to evaluate the effectiveness of a multi-level, multi-component de-implementation strategy to reduce unnecessary preoperative testing. Sixteen Michigan Value Collaborative (MVC)/Michigan Surgical Quality Collaborative (MSQC) sites in Michigan will implement several tools that have been proven to reduce unnecessary testing at a single site, including clinician education, a decision aid, audit and feedback on performance, and a pay-for-performance incentive. The researchers believe that, through the use of these strategies, there will be a significant reduction in unnecessary preoperative testing during the intervention.
What is being tested
- Active de-Implementation (behavioral)
Sponsor: University of Michigan · Participants: 16 · Started: Apr 1, 2025
Contact the study team
- Dana Greene Jr., MPH · Phone: (313)-670-0408
- Valerie Gavrila · Phone: 734-232-9961
Official record on ClinicalTrials.gov — NCT06934564
Locations in the U.S.
| Michigan | University of Michigan and other Michigan Surgical Quality Collaborative sites, Ann Arbor |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.